Tip Location Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032

Tip Location Devices Market by Product Type (Tip Location System and Accessories), Technology (ECG Based, ECG with Electromagnetic (EM) Navigation, and ECG with Ultrasound-Guided), End-User (Hospitals, Ambulatory Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2032 owing to the rising demand for PICCs & CVCs in chronic disease management and surge in product development drives investment in advanced tip confirmation systems.

The tip location devices market was valued at USD 221.17 million in 2024, growing at a CAGR of 4.39% during the forecast period from 2025 to 2032 to reach USD 311.01 million by 2032. The demand for tip location devices is being driven by several key factors, notably the rising use of peripherally inserted central catheters (PICCs) and central venous catheters (CVCs) in the management of chronic diseases such as cancer, renal failure, and cardiovascular conditions. In addition, the market is witnessing a surge in product innovation and technological advancement, with leading manufacturers investing in the development of sophisticated tip confirmation systems featuring ECG guidance, ultrasound integration, and wireless connectivity. Collectively, these factors are fueling strong market momentum and creating a favorable environment for sustained expansion, positioning the tip location devices market for robust and steady growth from 2025 to 2032.

Tip Location Devices Market Dynamics:

The rising demand for peripherally inserted central catheters (PICCs) and central venous catheters (CVCs) in chronic disease management is driving the growth of the tip location devices market. Precise catheter placement is essential for patient safety, effective treatment, and reducing complications such as malposition, migration, thrombosis, and infections. As healthcare facilities prioritize safety, efficiency, and compliance with best practices, the demand for advanced tip location devices continues to surge.

One of the primary drivers of market growth is the increasing incidence of cancer, kidney disease, critically ill newborns, and cardiovascular disorders. The rising prevalence of these conditions has led to an increased need for long-term intravenous (IV) therapies, subsequently escalating catheter insertions. According to data from the International Agency for Research on Cancer (2024), global estimates in 2022 indicated 487,000 new cases of leukemia, 82,500 cases of Hodgkin lymphoma, and 553,000 cases of non-Hodgkin lymphoma. These figures are projected to rise to 746,000, 109,000, and 890,000 cases, respectively, by 2045.

Leukemia and lymphoma patients rely on long-term IV access through CVCs and PICCs for chemotherapy, targeted therapies, and immunotherapy. The use of tip location devices, such as ECG-guided and electromagnetic systems, enhances placement accuracy, reduces reliance on X-rays, minimizes radiation exposure, and improves procedural efficiency. As a result, the adoption of these technologies is rapidly increasing in oncology treatment settings.

Furthermore, neonatal care is another key area fueling market expansion. According to the World Health Organization (2023), an estimated 13.4 million babies were born preterm globally. Preterm and critically ill newborns in neonatal intensive care units (NICUs) frequently require long-term IV therapy through PICCs and CVCs for essential nutrients and medications. Given the fragility of neonatal veins, precise catheter placement is critical to avoid complications such as thrombosis, infection, and organ damage. The growing emphasis on advanced neonatal care solutions has consequently driven the integration of tip location devices to ensure safe and accurate catheter placement in newborns.

Chronic kidney disease (CKD) also presents a significant market opportunity for tip location devices. Data from the International Society of Nephrology (2023) indicate that approximately 850 million people worldwide were affected by CKD. Patients in advanced stages or undergoing hemodialysis require reliable venous access for frequent dialysis treatments, medication administration, and IV fluid delivery. The high prevalence of CKD worldwide has heightened the demand for vascular access devices, thereby creating a parallel need for advanced tip location technologies to improve catheter placement accuracy and patient outcomes.

Moreover, in November 2023, BD announced the launch of its advanced ultrasound system designed to enhance clinician efficiency in placing PICCs, central venous catheters, IV lines, and other vascular access devices. The SiteRite™ 9 Ultrasound System featured a 15.6-inch touchscreen with enhanced image quality, offering industry-leading catheter placement tools. It incorporated integrated visualization technologies, including the Cue™ Needle Tracking System for real-time needle guidance and the Sherlock 3CG+™ Tip Confirmation System for accurate catheter tip placement.

However, the high cost of tip location devices, technical limitations & procedural challenges, among others, are some of the key constraints that may limit the growth of the tip location devices market.

Tip Location Devices Market Segment Analysis:

Tip Location Devices Market by Product Type (Tip Location System and Accessories), Technology (ECG Based, ECG with Electromagnetic (EM) Navigation, and ECG with Ultrasound-Guided), End-User (Hospitals, Ambulatory Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product type segment of the tip location devices market, the tip location system category is estimated to account for the largest market share of 88.06% in 2024. This can be attributed to the increasing global prevalence of oncological and infectious diseases, fueling the demand for tip location devices (TLDs). Additionally, these devices offer significant advantages over traditional catheter placement methods, further accelerating their adoption in clinical practice.

Tip location devices (TLDs) are essential medical tools designed to precisely guide and confirm the placement of Peripherally Inserted Central Catheters (PICCs) and Central Venous Catheters (CVCs). They ensure that the catheter tip reaches the optimal position in the lower third of the superior vena cava (SVC) near the cavoatrial junction (CAJ).

Misplaced catheters can lead to serious complications, including thrombosis, arrhythmia, and infections. TLDs significantly improve placement accuracy, minimizing the need for confirmatory X-rays and reducing procedural risks. As a result, hospitals and clinicians are increasingly adopting technology-driven solutions rather than relying solely on traditional accessories.

TLDs are higher-value products compared to single-use accessories. Accessories like ECG patches or sterile covers are low-cost consumables, whereas TLDs are premium-priced devices with higher profit margins. Hospitals prefer investing in advanced medical devices that reduce complications and improve efficiency. Additionally, X-ray and fluoroscopy were traditionally used to confirm catheter placement, but they increase radiation exposure and delay procedures due to additional imaging; thus, TLDs are replacing X-ray-based imaging systems, leading to higher demand for TLDs rather than accessories.

Further, the increasing number of product approvals and launches is also contributing to market growth. For instance, in February 2025, Navi Medical Technologies, a company specializing in pediatric healthcare innovations, announced that its Neonav ECG Tip Location System received 510(k) clearance from the U.S. Food and Drug Administration (FDA).

Given these factors, the tip location systems in the tip location devices market are expected to experience substantial revenue growth during the forecast period from 2025 to 2032.

North America is expected to dominate the overall tip location devices market:

North America is projected to hold the largest share of 48.64% in the tip location devices market in 2024, driven by several key factors. This regional dominance is primarily attributed to the rising prevalence of chronic diseases such as cancer, cardiovascular disorders, and kidney diseases, which require long-term intravenous therapies. The increasing adoption of PICCs and CVCs in hospitals and homecare settings is further fueling demand for advanced tip confirmation technologies. Collectively, these factors are positioning North America as the leading market in the global tip location devices market.

The increasing incidence of cancer, particularly breast and lung cancer, is significantly contributing to the rising demand for advanced vascular access technologies such as tip location devices. According to the International Agency for Research on Cancer (2025), in 2022, the estimated new cases of breast cancer were 306,000, with projections estimated to reach 384,000 cases by 2045 in North America. Similarly, as per the same source, in 2022, approximately 312,000 new cases of lung cancer in Canada were reported, with projections indicating a rise to 385,000 cases within the next five years. Furthermore, data from Lung Cancer Canada (2023) showed that over 32,000 Canadians were diagnosed with lung cancer each year.

Such high and growing cancer incidence rates are leading to an increased need for central venous catheterizations to support chemotherapy, parenteral nutrition, and other long-term treatments. Tip location devices play a critical role in ensuring accurate catheter placement, reducing complications, and improving procedural efficiency. As a result, the surge in oncology cases is directly fueling the adoption of these devices, thereby driving consistent growth in the global tip location devices market.

Additionally, the increase in product development activities among the key market players is further boosting the overall market across the region. For instance, in February 2021, Piccolo Medical received U.S. FDA clearance of its SmartPICC™ System for the positioning of peripherally inserted central catheters.

Therefore, considering all the above-mentioned factors, North America is positioned to have the largest share in the tip location devices market in the upcoming years.

Tip Location Devices Market Key Players:

Some of the key market players operating in the tip location devices market include BD, Teleflex Incorporated, Vygon (UK) Ltd., Navi Medical Technologies, Seda S.p.A., Piccolo Medical Inc., and others.

Recent Developmental Activities in the Tip Location Devices Market:

• In May 2023, Teleflex Incorporated announced the launch of two new devices designed to enhance PICC insertion and reduce complications. The Arrow® VPS Rhythm® DLX Device and NaviCurve™ Stylet, which were engineered to work together, offering vascular access specialists more efficient and predictable PICC placement. The VPS Rhythm® DLX Device provided real-time catheter tip location using the patient's cardiac electrical activity and featured an optional integrated ultrasound with a Catheter-to-Vessel ratio tool for standardized vessel measurement. Paired with the Arrow® PICC preloaded with the NaviCurve™ Stylet, the system introduced advanced tip navigation and location technologies. With TipTracker™ Technology, the VPS Rhythm® DLX Device eliminated the need for a confirmatory X-ray, streamlining the process from ultrasound vessel assessment to PICC navigation and final tip confirmation in the lower third of the superior vena cava.
• In July 2024, Access Vascular, Inc. announced that it was preparing to submit its HydroGUIDE™ catheter placement technology for FDA clearance. While AVI catheters were already compatible with various placement systems, the addition of HydroGUIDE™ reinforced the company's commitment to advancing vascular access. By integrating HydroGUIDE™ tip location technology with its MIMIX® vascular access devices, AVI sought to improve PICC line placement, reduce complications, and enhance patient care.

Key takeaways from the tip location devices market report study

• Market size analysis for current tip location devices market size (2024), and market forecast for 8 years (2025 to 2032)
• Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
• Key companies dominating the tip location devices market.
• Various opportunities available for the other competitors in the tip location devices market space.
• What are the top-performing segments in 2024? How these segments will perform in 2032?
• Which are the top-performing regions and countries in the current tip location devices market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for tip location devices market growth in the coming future?

Target audience who can benefit from this tip location devices market report study

• Tip location device product providers
• Research organizations and consulting companies
• Tip location devices-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and traders dealing in tip location devices
• Various end-users who want to know more about the tip location devices market and the latest technological developments in the tip location devices market

Frequently Asked Questions for the Tip Location Devices Market:

1. What are tip location devices?

• Tip location devices assist healthcare providers in accurately positioning catheters during vascular access procedures. They are essential for central venous catheterization and PICC placement. TLDs improve precision and patient safety in catheter positioning.

2. What is the market for tip location devices?

• The tip location devices market was valued at USD 221.17 million in 2024, growing at a CAGR of 4.39% during the forecast period from 2025 to 2032 to reach USD 311.01 million by 2032.

3. What are the drivers for the tip location devices market?

• The demand for tip location devices is being driven by several key factors, notably the rising use of peripherally inserted central catheters (PICCs) and central venous catheters (CVCs) in the management of chronic diseases such as cancer, renal failure, and cardiovascular conditions. In addition, the market is witnessing a surge in product innovation and technological advancement, with leading manufacturers investing in the development of sophisticated tip confirmation systems featuring ECG guidance, ultrasound integration, and wireless connectivity. Collectively, these factors are fueling strong market momentum and creating a favorable environment for sustained expansion, positioning the tip location devices market for robust and steady growth from 2025 to 2032.

4. Who are the key players operating in the tip location devices market?

• Some of the key market players operating in the tip location devices market include BD, Teleflex Incorporated, Vygon (UK) Ltd., Navi Medical Technologies, Seda S.p.A., Piccolo Medical Inc., and others.

5. Which region has the highest share in the tip location devices market?

• North America is projected to hold the largest share of the tip location devices market in 2024, driven by several key factors. This regional dominance is primarily attributed to the rising prevalence of chronic diseases such as cancer, cardiovascular disorders, and kidney diseases, which require long-term intravenous therapies. The increasing adoption of PICCs and CVCs in hospitals and homecare settings is further fueling demand for advanced tip confirmation technologies. Collectively, these factors are positioning North America as the leading market in the global tip location devices market.

This product will be delivered within 2 business days.